GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis

Heng Yin(Chongqing Medical University), Guanglun Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University)
International Journal of Oncology
September 5, 2017
Cited by 88


Related Papers